<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Introduction</h3>
<p>The COVID-19 pandemic has changed healthcare systems’ functioning and priorities worldwide, negatively impacting cancer screening. Adverse effects of delayed diagnosis of head and neck cancer (HNC) may be associated with poorer overall survival. The aim of the study was to assess the impact of the COVID-19 pandemic on HNC diagnosis.</p>
</sec>
<sec><h3>Materials and Methods</h3>
<p>A retrospective analysis of database records of patients diagnosed with HNC in a single tertiary center from March 1, 2020, until April 30, 2021 (COVID group) was performed and compared to the period from January 1, 2019, to February 30, 2020 (pre-COVID group). Patients’ general characteristics, disease extent in TNM classification, symptom duration, incidence of dyspnea at admission, emergency tracheotomy at admission, and indications for percutaneous endoscopic gastrostomy (PEG) were compared.</p>
</sec>
<sec><h3>Results</h3>
<p>One hundred and seventy-two patients with newly diagnosed HNC were enrolled. The most common tumor location was the larynx, followed by the hypopharynx. There were no significant differences between the groups in terms of the patients’ general or clinical characteristics, disease extent in TNM classification, and symptoms duration. However, the likelihood of PEG being performed in the COVID group was over three times higher (OR=3.15, 95% CI: 1.08 to 9.18, <italic>p</italic>=0.049).</p>
</sec>
<sec><h3>Conclusions</h3>
<p>During the pandemic, more patients had dysphagia or malnutrition requiring PEG. However, the pandemic did not affect the progression of patients’ HNC significantly.</p>
</sec>
</abstract>

Introduction
The COVID-19 pandemic has changed healthcare systems’ functioning and priorities worldwide, negatively impacting cancer screening. Adverse effects of delayed diagnosis of head and neck cancer (HNC) may be associated with poorer overall survival. The aim of the study was to assess the impact of the COVID-19 pandemic on HNC diagnosis.

Materials and Methods
A retrospective analysis of database records of patients diagnosed with HNC in a single tertiary center from March 1, 2020, until April 30, 2021 (COVID group) was performed and compared to the period from January 1, 2019, to February 30, 2020 (pre-COVID group). Patients’ general characteristics, disease extent in TNM classification, symptom duration, incidence of dyspnea at admission, emergency tracheotomy at admission, and indications for percutaneous endoscopic gastrostomy (PEG) were compared.

Results
One hundred and seventy-two patients with newly diagnosed HNC were enrolled. The most common tumor location was the larynx, followed by the hypopharynx. There were no significant differences between the groups in terms of the patients’ general or clinical characteristics, disease extent in TNM classification, and symptoms duration. However, the likelihood of PEG being performed in the COVID group was over three times higher (OR=3.15, 95% CI: 1.08 to 9.18, p=0.049).

Conclusions
During the pandemic, more patients had dysphagia or malnutrition requiring PEG. However, the pandemic did not affect the progression of patients’ HNC significantly.

The impact of the COVID-19 pandemic on head and neck cancer diagnosis: a single-center study

Department and Clinic of Otolaryngology Head and Neck Surgery

Postępy Higieny i Medycyny Doświadczalnej

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Introduction
The COVID-19 pandemic has changed healthcare systems’ functioning and priorities worldwide, negatively impacting cancer screening. Adverse effects...

The impact of the COVID-19 pandemic on head and neck cancer diagnosis: a single-center study

Article Category: Original Study

Online veröffentlicht: 25. Aug. 2023

Seitenbereich: 65 - 71

Eingereicht: 02. Feb. 2023

Akzeptiert: 12. Juni 2023

DOI: https://doi.org/10.2478/ahem-2023-0013

Schlüsselwörter
COVID-19, SARS-CoV-2, head and neck cancer, cancer diagnosis

© 2023 Marcin Turski et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The impact of the COVID-19 pandemic on head and neck cancer diagnosis: a single-center study

Article Category: Original Study

Online veröffentlicht: 25. Aug. 2023

Seitenbereich: 65 - 71

Eingereicht: 02. Feb. 2023

Akzeptiert: 12. Juni 2023

DOI: https://doi.org/10.2478/ahem-2023-0013

SchlüsselwörterCOVID-19, SARS-CoV-2, head and neck cancer, cancer diagnosis

© 2023 Marcin Turski et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Schlüsselwörter
COVID-19, SARS-CoV-2, head and neck cancer, cancer diagnosis